| Q42046394 | A block in virus-like particle maturation following assembly of murine leukaemia virus in insect cells |
| Q35826475 | A highly conserved residue in the C-terminal helix of HIV-1 matrix is required for envelope incorporation into virus particles |
| Q35842199 | A molecular determinant of human immunodeficiency virus particle assembly located in matrix antigen p17. |
| Q30386218 | A synergistic approach to protein crystallization: combination of a fixed-arm carrier with surface entropy reduction. |
| Q33846187 | Analysis of Mason-Pfizer monkey virus Gag particles by scanning transmission electron microscopy |
| Q45507217 | Assembly of human immunodeficiency virus precursor gag proteins |
| Q41052895 | Assembly of macromolecular complexes in bacterial and baculovirus expression systems |
| Q33809649 | Assembly of retrovirus capsid-nucleocapsid proteins in the presence of membranes or RNA. |
| Q34172241 | Atomic force microscopy and electron microscopy analysis of retrovirus Gag proteins assembled in vitro on lipid bilayers |
| Q27640101 | Atomic resolution structure of Moloney murine leukemia virus matrix protein and its relationship to other retroviral matrix proteins |
| Q27678797 | Biophysical characterization and crystal structure of the Feline Immunodeficiency Virus p15 matrix protein |
| Q34606804 | Biophysical characterization of the feline immunodeficiency virus p24 capsid protein conformation and in vitro capsid assembly |
| Q34065642 | Budding of enveloped viruses from the plasma membrane. |
| Q42058392 | Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography |
| Q44410414 | Control of human immunodeficiency virus type-1 protease activity in insect cells expressing Gag-Pol rescues assembly of immature but not mature virus-like particles |
| Q41079116 | Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle |
| Q39880951 | Cryo-electron microscopy structure of yeast Ty retrotransposon virus-like particles. |
| Q33782886 | Cryoelectron microscopic examination of human immunodeficiency virus type 1 virions with mutations in the cyclophilin A binding loop. |
| Q27729336 | Crystal structure of SIV matrix antigen and implications for virus assembly |
| Q27733334 | Crystal structure of dimeric HIV-1 capsid protein |
| Q27732646 | Crystal structures of the trimeric human immunodeficiency virus type 1 matrix protein: implications for membrane association and assembly |
| Q33784101 | Detection of a trimeric human immunodeficiency virus type 1 Gag intermediate is dependent on sequences in the matrix protein, p17. |
| Q36569418 | Discovery of a small-molecule antiviral targeting the HIV-1 matrix protein. |
| Q40317832 | Downregulation of human immunodeficiency virus type 1 Gag expression by a gp41 cytoplasmic domain fusion protein |
| Q37730805 | Effect of extension of the cytoplasmic domain of human immunodeficiency type 1 virus transmembrane protein gp41 on virus replication |
| Q45407731 | Evolution of feline immunodeficiency virus Gag proteins |
| Q39603298 | Formation of wild-type and chimeric influenza virus-like particles following simultaneous expression of only four structural proteins |
| Q39984546 | Generation of lentivirus vectors using recombinant baculoviruses |
| Q33782075 | Genetic determinants of Rous sarcoma virus particle size. |
| Q37187498 | HIV-1 matrix organizes as a hexamer of trimers on membranes containing phosphatidylinositol-(4,5)-bisphosphate |
| Q44080031 | Human immunodeficiency virus type 1 Gag assembly through assembly intermediates |
| Q35829873 | Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway. |
| Q36857103 | Human immunodeficiency virus type 1 assembly, release, and maturation. |
| Q35635123 | Human immunodeficiency virus type 1 matrix protein assembles on membranes as a hexamer |
| Q33818228 | Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures |
| Q39879873 | In vitro assembly of virus-like particles with Rous sarcoma virus Gag deletion mutants: identification of the p10 domain as a morphological determinant in the formation of spherical particles |
| Q33653475 | In vitro assembly properties of human immunodeficiency virus type 1 Gag protein lacking the p6 domain. |
| Q39720527 | In vitro selection of RNAs that bind to the human immunodeficiency virus type-1 gag polyprotein |
| Q56838778 | Is the C60 Fullerene Molecule Toxic?! |
| Q60304477 | Journey to the core of HIV |
| Q34435902 | Membrane binding of human immunodeficiency virus type 1 matrix protein in vivo supports a conformational myristyl switch mechanism |
| Q34999719 | Molecular organization of Mason-Pfizer monkey virus capsids assembled from Gag polyprotein in Escherichia coli. |
| Q38021264 | Molecular recognition in the human immunodeficiency virus capsid and antiviral design |
| Q40011798 | Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association |
| Q33835481 | Organization of immature human immunodeficiency virus type 1 |
| Q30873476 | Retrovirus capsid protein assembly arrangements |
| Q33794223 | Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly |
| Q39602742 | Structural consequences of cyclophilin A binding on maturational refolding in human immunodeficiency virus type 1 capsid protein. |
| Q39603597 | Structural flexibility and functional valence of CD4-IgG2 (PRO 542): potential for cross-linking human immunodeficiency virus type 1 envelope spikes |
| Q39744816 | Structural organization of authentic, mature HIV-1 virions and cores |
| Q57065085 | Structural similarity between the p17 matrix protein of HIV-1 and interferon-γ |
| Q27637386 | Structure of equine infectious anemia virus matrix protein |
| Q35882404 | Structure-function studies of the human immunodeficiency virus type 1 matrix protein, p17. |
| Q36485425 | Supramolecular organization of immature and mature murine leukemia virus revealed by electron cryo-microscopy: implications for retroviral assembly mechanisms |
| Q45432280 | The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor |
| Q37613762 | The capsid protein of human immunodeficiency virus: intersubunit interactions during virus assembly |
| Q30341481 | The central domain of the matrix protein of HIV-1: influence on protein structure and virus infectivity. |
| Q41075060 | The solution structure of the bovine leukaemia virus matrix protein and similarity with lentiviral matrix proteins. |
| Q33887537 | The three-dimensional solution structure of the matrix protein from the type D retrovirus, the Mason-Pfizer monkey virus, and implications for the morphology of retroviral assembly |
| Q41070391 | The use of antibody fragments for crystallization and structure determinations |
| Q33947325 | The yeast Ty virus-like particles |
| Q37415605 | Total chemical synthesis of N-myristoylated HIV-1 matrix protein p17: structural and mechanistic implications of p17 myristoylation |
| Q33632676 | Towards the structure of the human immunodeficiency virus: divide and conquer |
| Q34068037 | Virus maturation by budding |
| Q33718140 | Virus particle core defects caused by mutations in the human immunodeficiency virus capsid N-terminal domain |